Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.09 0.28 −1.52%
Market cap
$382.4M
P/E
0.0×
Fwd P/E
−8.4×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Dec '25 Dec '24
P/E ratio
0.00 0.00
Altman Z-Score
2.53 —
P/S ratio
2.62 0.05
Altman Z″-Score (non-manufacturers)
7.68 (1.53)
P/FCF ratio
0.00 0.00
P/Operating CF
(14.12) (0.36)
Beneish M-Score
(2.42) —
P/B ratio
0.88 0.00
Price to Tangible BV
0.88 0.00
EV/Sales
0.31 (0.63)
EV/EBITDA
0.00 1.45
EV/Operating CF
(0.51) 1.19
EV/FCF
(0.41) 0.98
Quick Ratio
9.34 2.64
Current Ratio
11.07 4.59
Net Debt/EBITDA
4.79 0.03
Debt/Assets
8.78% 34.03%
Debt/Equity
0.11 0.74
Asset Turnover
0.44 0.00
Operating CF/Net income
0.71 0.91
Capex/Depreciation
(2.14) (1.60)
Interest Coverage
(375.67) (11.13)
ROE
(93.80%) 0.00%
ROA
(37.90%) 0.00%
ROIC
(52.42%) (47.22%)
Return on Tangible Assets
(25.95%) (44.67%)
Average Days of Receivables
63.78 59.12
Research and Development Expense of Revenue
16.34% 14.20%
Selling, General and Administrative Expense of Revenue
115.75% 109.11%
Intangible Assets out of Total Assets
0.00 0.01
Share Based Compensation of Revenue
2.10% 2.38%
Graham Net Nets
1.03 22.67
Graham Number
0.00 0.00
Earnings Yield
(1,529.23%) (2,386.39%)
Free Cash Flow Yield
(29.04%) (1,356.23%)
Revenue per Share
5.46 490.28
Operating CF per Share
(3.30) (219.27)
Capex per Share
(0.85) (62.25)
Free Cash Flow per Share
(4.15) (281.52)
Cash per Share
14.33 233.24
Shareholders Equity per Share
16.23 306.67
Interest Debt per Share
0.00 0.00
Book value per Share
16.23 306.67
Free Cash Flow
(36.02) (18.16)
Working Capital
142.97 27.48
Capital Expenditures
(7.41) (4.01)
Net Current Asset Value
128.01 11.83
EV/EBIT
0.00 1.28
Capex to Sales
0.16 0.13
Price to Operating Income
0.00 0.00
Other line items
Depreciation/Fixed assets
0.28 0.33
Cash ROIC
(12.87%) (36.70%)
Accounts Receivable Turnover
7.07 0.00
Accounts Payable Turnover
1.62 0.00
Inventory Turnover
0.63 0.00
Average Days of Payables
291.41 243.60
Days of Inventory on Hand
709.02 699.47
Average Receivables
6.70 —
Average Payables
6.87 —
Average Inventory
17.77 —
Average Assets
106.49 —
Average Common Equity
43.03 —

Fold the line items

Columns are period end dates